
Genetic Technologies Limited GENE
Annual report 2022
added 08-30-2022
Genetic Technologies Limited ROE Ratio 2011-2025 | GENE
Annual ROE Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.4 | -32.87 | -44.99 | -362.78 | -115.96 | -79.44 | -71.18 | -46.47 | -554.04 | -161.48 | -36.71 | 13.35 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.35 | -554.04 | -128.0 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 16.58 | -1.6 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.71 | 6.1 % | $ 179 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.58 | -2.47 % | $ 2.01 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 38.44 | -0.49 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.99 | 0.84 % | $ 340 M | ||
|
DexCom
DXCM
|
26.18 | $ 66.4 | -0.84 % | $ 25.6 B | ||
|
Danaher Corporation
DHR
|
7.87 | $ 225.84 | -0.29 % | $ 165 B | ||
|
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.51 | 0.01 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 26.69 | -1.66 % | $ 807 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-72.81 | $ 20.03 | -2.58 % | $ 1.08 B | ||
|
Celcuity
CELC
|
-96.68 | $ 103.28 | -1.87 % | $ 4.07 B | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-62.78 | $ 3.51 | -1.96 % | $ 112 K | ||
|
Co-Diagnostics
CODX
|
-41.08 | $ 0.31 | -9.05 % | $ 9.1 M | ||
|
Quidel Corporation
QDEL
|
60.8 | $ 28.36 | -1.53 % | $ 1.19 B | ||
|
IQVIA Holdings
IQV
|
22.63 | $ 221.47 | -0.34 % | $ 40.2 B | ||
|
Guardant Health
GH
|
312.48 | $ 103.88 | 1.77 % | $ 12.8 B | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 133.44 | -1.06 % | $ 21.2 B | ||
|
Charles River Laboratories International
CRL
|
0.64 | $ 196.03 | 1.58 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 184.35 | 1.01 % | $ 20.5 B | ||
|
Biodesix
BDSX
|
-205.65 | $ 7.87 | 0.31 % | $ 1.02 B | ||
|
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 262.08 | -0.79 % | $ 22 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 184.11 | -1.32 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
55.65 | $ 701.53 | -0.38 % | $ 57.9 B | ||
|
Mettler-Toledo International
MTD
|
-680.23 | $ 1 404.18 | 0.73 % | $ 29.8 B | ||
|
Lantheus Holdings
LNTH
|
28.72 | $ 67.07 | 0.67 % | $ 4.64 B | ||
|
Myriad Genetics
MYGN
|
-18.16 | $ 6.99 | -3.01 % | $ 633 M | ||
|
Agilent Technologies
A
|
22.45 | $ 140.39 | 0.52 % | $ 42.7 B | ||
|
NeoGenomics
NEO
|
-8.72 | $ 11.94 | 0.76 % | $ 1.51 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 6.77 | -1.31 % | $ 1.47 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.52 | -2.5 % | $ 5.79 M | ||
|
Bioventus
BVS
|
-90.0 | $ 7.54 | -0.13 % | $ 472 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K |